Rivus Pharmaceuticals, Inc.
Clinical trials sponsored by Rivus Pharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug HU6 targets fatty liver disease in Mid-Stage trial Results expected Feb 2027 (estimated)